Predominance of a type 2 intratumoural immune response in fresh tumour-infiltrating lymphocytes from human gliomas

Clinical and Experimental Immunology

Volumn 105, Issue 2, 1996, Pages 344-352

  Roussel, E ^a,b,c   Gingras, M C ^a,b   Grimm, E A ^a   Bruner, J M ^a   Moser, R P ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c GenePrint Corp   (United States)

Author keywords

Cell adhesion molecules; lymphokines; mRNA; Th2 cels; Tumour infiltrating lymphocytes

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; LYMPHOTOXIN; MESSENGER RNA;

ARTICLE; CELL ADHESION; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0030018396     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-753.x     Document Type: Article

References (45)

1. Whiteside TL, Jost LM, Herberman RB. Tumor-infiltrating lymphocytes. Potential and limitations to their use for cancer therapy. Crit Rev Oncol Hematol 1992; 12:25-47.
2. Farmer J, Antel J, Freedman M, Cashman N, Rode H, Villemure J. Characterization of lymphoid cells isolated from human gliomas. J Neurosurg 1989; 71:528-33.
3. Miescher S, Whiteside T, de Tribolet N, Von Fliedner V. In situ characterization, clonogenic potential, and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancers. J Neurosurg 1988; 68:438-48.
4. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346:425-34.
5. Makgoba MW, Sanders ME, Shaw S. The CD2-LFA-3 and LFA-1-ICAM pathways: relevance to T-cell recognition. Immunol Today 1989; 10:417-22.
6. Pardi R, Inverardi L, Bender JR. Regulatory mechanisms in leukocyte adhesion: flexible receptors for sophisticated travelers. Immunol Today 1992; 13:224-30.
7. Balkwill FR, Burke F. The cytokine network. Immunol Today 1989; 10:299-304.
8. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994; 12:227-57.
9. + T cells. Annu Rev Immunol 1994; 12:635-73.
10. Hemler ME. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol 1990; 8:365-400.
11. Chadburn A, Inghirami G, Knowles DM. The kinetics and temporal expression of T-cell activation-associated antigens CD15 (LeuM1), CD30 (Ki-1), EMA, and CD11c (LeuM5) by benign activated T cells. Hematol Pathol 1992; 6:193-202.
12. Sanders ME, Makgoba MW, Sharrow SO, et al. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production. J Immunol 1988; 140:1401-7.
13. Ehlers S, Smith KA. Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory. J Exp Med 1991; 173:25-36.
14. OGarra A, Vieira P. Polymerase chain reaction for detection of cytokine gene expression. Curr Opin Immunol 1992; 4:211-5.
15. Whiteside TL, Miescher S, MacDonald HR, Von Fliedner V. Separation of tumor-infiltrating lymphocytes from tumor cells in human solid tumors. A comparison between velocity sedimentation and discontinuous density gradients. J Immunol Methods 1986; 90:221-33.
16. Roussel E. Immunoregulatory leucocyte subset typing and PHA response in relation to the nutritional state in cancer patients with gastrointestinal neoplasia. Diagn Immunol 1986; 4:10-16.
17. Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 1986; 136:4480-6.
18. Ruoslahti E, Giancotti FG. Integrins and tumor cell dissemination. Cancer Cells 1989; 1:119-26.
19. Rosenman SJ, Gallatin WM. Cell surface glycoconjugates in intercellular and cell-substratum interactions. Semin Cancer Biol 1991; 2:357-66.
20. Paulson JC. Selectin/carbohydrate-mediated adhesion of leukocytes. In: Harlan JM, Liu DY, eds. Adhesion - its role in inflammatory disease. New York: W.H. Freeman and Co., 1992;19-42.
21. Imai Y, Lasky LA, Rosen SD. Further characterization of the interaction between L-selectin and its endothelial ligands. Glycobiology 1992; 2:373-81.
22. Tobias PS, Mathison J, Mintz D et al. Participation of lipopolysaccharide-binding protein in lipopolysaccharide-dependent macrophage activation. Am J Respir Cell Mol Biol 1992; 7:239-45.
23. Pilarski LM, Yacyshyn BR, Jensen GS, Pruski E, Pabst HF. Beta 1 integrin (CD29) expression on human postnatal T cell subsets defined by selective CD45 isoform expression. J Immunol 1991; 147:830-7.
24. Lanier LL, Le AM, Ding A et al. Expression of Leu-19 (NKH-1) antigen on IL-2-dependent cytotoxic and non-cytotoxic T cell lines. J Immunol 1987; 138:2019-23.
25. Majdic O, Liszka K, Lutz D, Knapp W. Myeloid differentiation antigen defined by a monoclonal antibody. Blood 1981; 58:1127-33.
26. Macher BA, Buehler J, Scudder P, Knapp W, Feizi T. A novel carbohydrate, differentiation antigen on fucogangliosides of human myeloid cells recognized by monoclonal antibody VIM-2. J Biol Chem 1988; 263:10186-91.
27. Tiemeyer M, Swiedler SJ, Ishihara M et al. Carbohydrate ligands for endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 1991; 88:1138-42.
28. Shimizu Y, Newman W, Tanaka Y, Shaw S. Lymphocyte interactions with endothelial cells. Immunol Today 1992; 13:106-12.
29. Kanof ME, James SP. Leu-8 antigen expression is diminished during cell activation but does not correlate with effector function of activated T lymphocytes. J Immunol 1988; 140:3701-6.
30. Picker LJ, Terstappen LW, Rott LS, Streeter PR, Stein H, Butcher EC. Differential expression of homing-associated adhesion molecules by T cell subsets in man. J Immunol 1990; 145:3247-55.
31. Pattanapanyasat K, Hoy TG. Expression of cell surface transferrin receptor and intracellular ferritin after in vitro stimulation of peripheral blood T lymphocytes. Eur J Haematol 1991; 47:140-5.
32. Buck KJ, Harris RA, Sikela JM. A general method for quantitative PCR analysis of mRNA levels. Biotechniques 1991; 11:636-41.
33. Maral J, Florentin I, Soubrane C, Maral R. Cancer and immunosuppression: experimental aspects. Bull Cancer 1983; 70:351-71.
34. Mizoguchi H, OShea JJ, Longo DL, Loeffler CM, McVicar DW, Ochoa AC. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 1992; 258:1795-8.
35. de Waal Malefyt R, Yssel H, Spits H et al. Human T cell leukemia virus type I prevents cell surface expression of the T cell receptor through down-regulation of the CD3-gamma, -delta, -epsilon, and -zeta genes. J Immunol 1990; 145:2297-303.
36. Transy C, Moingeon PE, Marshall B, Stebbins C, Reinherz EL. Most anti-human CD3 monoclonal antibodies are directed to the CD3 epsilon subunit. Eur J Immunol 1989; 19:947-50.
37. Salmeron A, Sanchez-Madrid F, Ursa MA, Fresno M, Alarcon B. A conformational epitope expressed upon association of CD3-epsilon with either CD3-delta or CD3-gamma is the main target for recognition by anti-CD3 monoclonal antibodies. J Immunol 1991; 147:3047-52.
38. Kuppner M, Hamou M, de Tribolet N. Activation and adhesion molecule expression on lymphoid infiltrates in human glioblastomas. J Neuroimmunol 1990; 29:229-38.
39. Roussel E, Gingras MC, Grimm EA et al. High expression of adhesion/activation markers with little interleukin-2, interferon γ and tumor necrosis factor β gene activation in fresh tumor-infiltrating lymphocytes from lung adenocarcinoma. Cancer Immunol Immunother 1995; 41:1-9.
40. Corrigan CJ, Hamid Q, North J et al. Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy. Am J Respir Cell Mol Biol 1995; 12:567-78.
41. +) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin. J Immunol 1992; 148:2058-61.
42. + T cells secreting Th1 or Th2 cytokines. Immunity 1995; 2:271-9.
43. Maxwell M, Galanopoulos T, Neville Golden J, Antoniades H. Effect of the expression of transforming growth factor-beta 2 in primary human glioblastomas on immunosuppression and loss of immune surveillance. J Neurosurg 1992; 76:799-804.
44. Grimm E, Bruner J, Carinhas J et al. Characterization of interleukin-2-initiated versus OKT3-initiated human tumor-infiltrating lymphocytes from glioblastoma multiforme: growth characteristics, cytolytic activity, and cell phenotype. Cancer Immunol Immunother 1991; 32:391-9.
45. Yamamura M, Modlin R, Ohmen J, Moy R. Local expression of antiinflammatory cytokines in cancer. J Clin Invest 1993; 91:1005-10.